CryoPort Total Long Term Liabilities 2010-2025 | CYRX
CryoPort total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
CryoPort Annual Total Long Term Liabilities
(Millions of US $) |
| 2024 |
$237 |
| 2023 |
$423 |
| 2022 |
$442 |
| 2021 |
$428 |
| 2020 |
$135 |
| 2019 |
$4 |
| 2018 |
$15 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2016 |
$1 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$1 |
| 2012 |
$1 |
| 2011 |
$2 |
| 2010 |
$4 |
| 2009 |
$2 |
CryoPort Quarterly Total Long Term Liabilities
(Millions of US $) |
| 2025-03-31 |
$227 |
| 2024-12-31 |
$237 |
| 2024-09-30 |
$222 |
| 2024-06-30 |
$392 |
| 2024-03-31 |
$422 |
| 2023-12-31 |
$423 |
| 2023-09-30 |
$418 |
| 2023-06-30 |
$446 |
| 2023-03-31 |
$446 |
| 2022-12-31 |
$442 |
| 2022-09-30 |
$437 |
| 2022-06-30 |
$434 |
| 2022-03-31 |
$427 |
| 2021-12-31 |
$428 |
| 2021-09-30 |
$136 |
| 2021-06-30 |
$139 |
| 2021-03-31 |
$135 |
| 2020-12-31 |
$135 |
| 2020-09-30 |
$119 |
| 2020-06-30 |
$117 |
| 2020-03-31 |
$6 |
| 2019-12-31 |
$4 |
| 2019-09-30 |
$19 |
| 2019-06-30 |
$19 |
| 2019-03-31 |
$16 |
| 2018-12-31 |
$15 |
| 2018-09-30 |
$0 |
| 2018-06-30 |
$0 |
| 2018-03-31 |
$0 |
| 2017-12-31 |
$0 |
| 2017-09-30 |
$0 |
| 2017-06-30 |
$0 |
| 2017-03-31 |
$0 |
| 2016-12-31 |
$0 |
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
$1 |
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
$0 |
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$1 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$2 |
| 2010-12-31 |
$3 |
| 2010-09-30 |
$3 |
| 2010-06-30 |
$4 |
| 2010-03-31 |
$4 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$2 |
| 2009-06-30 |
$2 |
| 2009-03-31 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Transportation |
Transportation - Services |
$0.379B |
$0.228B |
|
CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150? Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.
|
